Thomas Cairns

2.8k total citations
63 papers, 1.4k citations indexed

About

Thomas Cairns is a scholar working on Surgery, Rheumatology and Nephrology. According to data from OpenAlex, Thomas Cairns has authored 63 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 13 papers in Rheumatology and 12 papers in Nephrology. Recurrent topics in Thomas Cairns's work include Xenotransplantation and immune response (13 papers), Renal Diseases and Glomerulopathies (10 papers) and Organ Transplantation Techniques and Outcomes (9 papers). Thomas Cairns is often cited by papers focused on Xenotransplantation and immune response (13 papers), Renal Diseases and Glomerulopathies (10 papers) and Organ Transplantation Techniques and Outcomes (9 papers). Thomas Cairns collaborates with scholars based in United Kingdom, Australia and Sweden. Thomas Cairns's co-authors include David Taube, Liz Lightstone, Charles D. Pusey, Megan Griffith, Jeremy Levy, Stephen P. McAdoo, Neill Duncan, Ruth J. Pepper, Jack Galliford and Bo E. Samuelsson and has published in prestigious journals such as Nature Communications, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Thomas Cairns

61 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Cairns United Kingdom 20 384 344 331 326 292 63 1.4k
Antoine G. Sreih United States 22 468 1.2× 104 0.3× 124 0.4× 701 2.2× 189 0.6× 57 1.3k
Ariella Kelman United States 14 801 2.1× 116 0.3× 53 0.2× 117 0.4× 261 0.9× 16 1.7k
Iuliana Shapira United States 20 127 0.3× 141 0.4× 65 0.2× 247 0.8× 65 0.2× 53 1.6k
Judit Demeter Hungary 18 146 0.4× 159 0.5× 58 0.2× 67 0.2× 562 1.9× 117 1.6k
F Invernizzi Italy 14 274 0.7× 119 0.3× 38 0.1× 303 0.9× 183 0.6× 39 1.0k
Peter D. Thomson South Africa 16 83 0.2× 123 0.4× 196 0.6× 160 0.5× 29 0.1× 39 732
Ronald P. Pelletier United States 29 33 0.1× 1.1k 3.3× 364 1.1× 376 1.2× 48 0.2× 104 2.8k
Olayemi Sokumbi United States 16 355 0.9× 124 0.4× 30 0.1× 128 0.4× 41 0.1× 89 1.1k
David Nicol Australia 23 61 0.2× 185 0.5× 31 0.1× 506 1.6× 86 0.3× 65 1.5k
Raphaël Szalat United States 19 94 0.2× 67 0.2× 73 0.2× 46 0.1× 157 0.5× 64 954

Countries citing papers authored by Thomas Cairns

Since Specialization
Citations

This map shows the geographic impact of Thomas Cairns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Cairns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Cairns more than expected).

Fields of papers citing papers by Thomas Cairns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Cairns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Cairns. The network helps show where Thomas Cairns may publish in the future.

Co-authorship network of co-authors of Thomas Cairns

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Cairns. A scholar is included among the top collaborators of Thomas Cairns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Cairns. Thomas Cairns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cairns, Thomas, et al.. (2022). Immune gene expression and functional networks in distinct lupus nephritis classes. Lupus Science & Medicine. 9(1). e000615–e000615. 4 indexed citations
2.
Edwards, Helena, Maria Prendecki, Thomas Cairns, et al.. (2021). Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis. Kidney International. 100(6). 1316–1324. 38 indexed citations
3.
Pepper, Ruth J., Stephen P. McAdoo, Sarah Moran, et al.. (2018). A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis. Lara D. Veeken. 58(2). 1119–1119. 58 indexed citations
4.
McAdoo, Stephen P., et al.. (2016). Ofatumumab for B cell depletion therapy in ANCA-associated vasculitis: a single-centre case series. Lara D. Veeken. 55(8). 1437–1442. 31 indexed citations
5.
Singh, Seema, P. Choi, Albert Power, et al.. (2012). Ten-year patient survival on maintenance haemodialysis: association with treatment time and dialysis dose. Journal of Nephrology. 26(4). 763–770. 16 indexed citations
6.
Cairns, Thomas. (2010). The supply side of labor: HR must be ready to steer organizations to the future. Employment Relations Today. 37(3). 1–8.
7.
Power, Albert, Seema Singh, Damien Ashby, et al.. (2009). Translumbar central venous catheters for long-term haemodialysis. Nephrology Dialysis Transplantation. 25(5). 1588–1595. 34 indexed citations
8.
Ashby, Damien, Daniel P. Gale, Mark Busbridge, et al.. (2009). Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica. 95(3). 505–508. 150 indexed citations
9.
Borrows, Richard, Marina Loucaidou, Thomas Cairns, et al.. (2005). Steroid Sparing in Renal Transplantation With Tacrolimus and Mycophenolate Mofetil: Three-Year Results. Transplantation Proceedings. 37(4). 1792–1794. 6 indexed citations
10.
11.
Loucaidou, Marina, Richard Borrows, Thomas Cairns, et al.. (2005). Late Steroid Withdrawal for Renal Transplant Recipients on Tacrolimus and MMF Is Safe. Transplantation Proceedings. 37(4). 1795–1796. 9 indexed citations
12.
Duncan, Neill, Ajay Dhaygude, Joel Owen, et al.. (2004). Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy. Nephrology Dialysis Transplantation. 19(12). 3062–3067. 59 indexed citations
13.
Cairns, Thomas, et al.. (2001). Red cell traverse through thin glomerular basement membranes. Kidney International. 59(6). 2069–2072. 39 indexed citations
14.
McKane, William, et al.. (2001). Treatment of calcineurin inhibitor toxicity by dose reduction plus introduction of mycophenolate mofetil. Transplantation Proceedings. 33(1-2). 1224–1225. 14 indexed citations
15.
McKane, William, et al.. (2000). IgG 2 ANTI-GAL??1???3GAL DOES NOT INDUCE PORCINE AORTIC ENDOTHELIAL CELL ACCOMMODATION IN VITRO. Transplantation. 70(7). 1085–1093. 3 indexed citations
16.
Lee, Janet, Thomas Cairns, William McKane, et al.. (1998). DEMONSTRATION OF IgM ANTIBODIES OF HIGH AFFINITY WITHIN THE ANTI-GAL??1-3GAL ANTIBODY REPERTOIRE. Transplantation. 66(8). 1117–1119. 12 indexed citations
17.
Papalois, Vassilios, et al.. (1998). Collagenase Digestion of the Pig Pancreas Modifies the Expression of GALα1-3GAL, Pk, and Thomsen–Friedenreich Antigens on Adult Porcine Islets. Transplantation Proceedings. 30(2). 656–656. 1 indexed citations
18.
Cairns, Thomas, et al.. (1998). Chemical and lectin‐gold electron microscopical studies of the expression of the Galα1‐determinant in the pig aorta. Xenotransplantation. 5(4). 246–256. 13 indexed citations
19.
Cairns, Thomas, Lee J, T. Cook, et al.. (1996). Thomsen-Friedenreich and PK antigens in pig-to-human xenotransplantation.. PubMed. 28(2). 795–6. 11 indexed citations
20.
Cairns, Thomas, et al.. (1995). INHIBITION OF THE PIG TO HUMAN XENOGRAFT REACTION, USING SOLUBLE GALα1–3GAL AND GALαl-3GALβl-4GlcNAc. Transplantation. 60(11). 1202–1207. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antoine G. Sreih Breakdown of academic impact, for papers by Ariella Kelman Breakdown of academic impact, for papers by Iuliana Shapira Breakdown of academic impact, for papers by Judit Demeter Breakdown of academic impact, for papers by F Invernizzi Breakdown of academic impact, for papers by Peter D. Thomson Breakdown of academic impact, for papers by Ronald P. Pelletier Breakdown of academic impact, for papers by Olayemi Sokumbi Breakdown of academic impact, for papers by David Nicol Breakdown of academic impact, for papers by Raphaël Szalat
Rankless by CCL
2026